Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.07
-0.53 (-8.03%)
At close: Mar 24, 2026, 4:00 PM EDT
6.05
-0.02 (-0.30%)
After-hours: Mar 24, 2026, 6:53 PM EDT

Cartesian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-130.3-77.42-219.7135.38-25.69
Depreciation & Amortization
2.961.150.841.291.25
Stock-Based Compensation
10.526.5822.5211.197.72
Other Adjustments
50.9451.81140.21-19.114.53
Change in Receivables
-0.247.980.910.16-2.69
Changes in Accounts Payable
1.07-2.932.830.09-0.22
Changes in Accrued Expenses
-3.59-6.74-2.762.211.06
Changes in Income Taxes Payable
----0.60.6
Changes in Unearned Revenue
--5.855.26-64.71-45.5
Changes in Other Operating Activities
-5.31.75-1.272.47-1.45
Operating Cash Flow
-73.94-23.67-51.16-31.63-60.38
Capital Expenditures
-5.45-9.09-0.21-1.2-1.09
Sale of Property, Plant & Equipment
-0.35---
Purchases of Investments
----33.5-32.46
Proceeds from Sale of Investments
--28.2519.716.4
Other Investing Activities
--6.56--
Investing Cash Flow
-5.45-8.7434.61-15-17.14
Long-Term Debt Repaid
---27.46--
Net Long-Term Debt Issued (Repaid)
---27.46--
Issuance of Common Stock
0.32128.490.2339.3352.9
Repurchase of Common Stock
---6.17--
Net Common Stock Issued (Repurchased)
0.32128.49-5.9439.3352.9
Issuance of Preferred Stock
-4020.25--
Net Preferred Stock Issued (Repurchased)
-4020.25--
Other Financing Activities
-8.38-0.07--0.11-
Financing Cash Flow
-8.06168.43-13.1539.2252.9
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.05-0.02-0.050.02-0
Net Cash Flow
-87.41135.99-29.75-7.4-24.63
Free Cash Flow
-79.4-32.77-51.37-32.83-61.47
FCF Margin
-2838.58%-84.21%-197.53%-29.64%-72.25%
Free Cash Flow Per Share
-3.06-1.89-9.93-0.23-0.54
Levered Free Cash Flow
-140.62-99.14-242.47-25.07-71.02
Unlevered Free Cash Flow
-144.27-65.77-74.84-45.65-57.48
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q